Search

Have you succeeded or failed to isolate Mycobacterium abscessus phages? We are setting up a new lab in Florida and looking for tips —Johan Wikström

The PASTEUR Act is a US bill that would incentivize the development of antibiotics. The Pew Charitable Trusts is urging people to ask their members of Congress to include the PASTEUR Act in the congressional omnibus package that lawmakers a

In a new paper in Cell Chemical Biology, Quirin Emslander and colleagues present a new cell-free platform for personalized production, transient engineering, and proteomic characterization of a broad spectrum of phages.

Emily Agnello et al. present the structure of the P74-26 tail tube and introduce an in vitro system for studying the kinetics of tube assembly.

In a new paper published in Nature Ecology & Evolution, Martin Guillemet et al. study the effect of coevolving phage populations on the diversification of bacterial CRISPR immunity across space and time. They demonstrate that the negative-f

In a new preprint on bioRxiv, Eligo Bioscience researchers engineer a phage-derived particle to deliver a base editor and modify E. coli colonizing the mouse gut.

Dear Phage Phans, We'd love to hear all your VoM Portugal stories— esp. since we couldn't go! Email or tweet us, and we'll post them here in Capsid! jessica@phage.directory / @phagedirectory — also send us pics! What was your favorite tal

Dear Phage Family, I have trouble isolating Listeria phages from environmental samples. I used the method from the article named 'Silage Collected from Dairy Farms Harbors an Abundance of Listeriaphages with Considerable Host Range and Gen

The National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) and the National Institute of Allergy and Infectious Diseases (NIAID) are hosting a joint workshop on bacteriophage therapy on October 25, 2022

The National Institute of Allergy and Infectious Diseases (NIAID) has begun a clinical trial for phage therapy in adults with cystic fibrosis, under the leadership of IPATH. The trial plans to enroll 72 participants across 16 cystic fibrosi

Phagos, a French phage manufacturing company, announced the closing of a €2.4 million Seed investment round co-led by Demeter (Paris) and Hoxton Ventures (London).

Adaptive Phage Therapeutics (APT) has announced that the Defense Health Agency (DHA) has awarded an additional $5 million to support clinical development of APT’s adaptive bacteriophage therapy in treatment of diabetic foot osteomyelitis (D

SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage Therapies, by Sahan B. W. Liyanagedera and colleagues, proposes the SpyPhage system where a “scaffold” bacteriophage is engineered to incorporate a SpyTag moiety on

In this Nature Communications paper, Brieuc Van Nieuwenhuyse (Université Catholique de Louvain) and colleagues report the story of a toddler who suffered from extensively drug-resistant Pseudomonas aeruginosa sepsis after liver transplantat

In a new paper in Molecular Ecology, Tue Kjærgaard Nielsen (University of Copenhagen) and colleagues review current approaches to detect nucleotide modifications, including hardware and software, and look onward to future applications, espe

Paweł Działak (AGH University of Science and Technology) and colleagues published a new paper in the journal Biogeosciences entitled Do bacterial viruses affect framboid-like mineral formation?

Bennett J. Davenport et al. published a new paper in npj Vaccines entitled Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.

In a new paper in International Journal of Food Microbiology, Amel Chaïb (University of Bordeaux) and colleagues review the current knowledge about bacteriophages of Oenococcus oeni and their possible impacts on the trajectory of the microb

In this Nature Microbiology paper, Christopher N. Vassallo and colleagues used an experimental selection scheme agnostic to genomic context to identify phage defence systems in 71 diverse E. coli strains. They found 21 conserved defence sys

Genome Startup Day Fall 2022: Bacteria Breakthroughs is a virtual event on October 5th, 2:00-3:00 pm PST that will feature a fireside chat with John Eisen, PhD, UC Davis professor and renowned genomics and microbiology researcher, and Ivan